SABIC Completes Buy of Shell's SADAF Stake

06:38 EDT 21 Aug 2017 | CHEManager

SABIC has completed the purchase of partner Shell Arabia’s half of their 50:50 joint venture SADAF for $820 million. The transfer plans were announced on Jan. 22. The Saudi petrochemicals giant is exercising an option of the original agreement allowing it to renew or end the partnership by the end of 2020.

Original Article: SABIC Completes Buy of Shell's SADAF Stake


More From BioPortfolio on "SABIC Completes Buy of Shell's SADAF Stake"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...